http://www.bing.com/news/search?q=biogen&setmkt=en-US&FORM=BNFD&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=biogen&setmkt=en-US&FORM=BNFD&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2ffinance.yahoo.com%2fhealthcare%2farticles%2fbiogen-acquires-raythera-deal-worth-134030709.html&c=3957282663976275933&mkt=en-usThe deal adds multiple small-molecule anti-inflammatory drug candidates to Biogen's pipeline, with the lead asset set to begin human trials this summer ...Thu, 18 Jun 2026 06:52:00 GMTYahoo Financehttp://www.bing.com/th?id=ONUT.W_ERAY_1PA4fPpU-SkWfxw&pid=Newsw={0}&h={1}&c=141200675http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fmarkets%2fbiogen-targets-immunology-growth-with-1-billion-raythera-deal%2far-AA25Ys0Y&c=14848027443065683195&mkt=en-usJune 17 (Reuters) - Biogen has struck a deal to acquire private biotechnology company RayThera for up to $1 billion, the companies said on Wednesday, as the U.S.-listed drugmaker seeks to expand its ...Thu, 18 Jun 2026 07:24:49 GMTReuters on MSNhttp://www.bing.com/th?id=ONUT.rtOgyzekaOY6gMvNL7NLow&pid=Newsw={0}&h={1}&c=14800533http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fpharmaphorum.com%2fnews%2fbiogen-pens-1bn-deal-buy-immunology-biotech-raythera&c=16013565515081116937&mkt=en-usBiogen has dipped its toe into the M&A waters once again, agreeing to buy San Diego-based RayThera for up to $1 billion in its second takeover this year. Buying RayThera will give ...Thu, 18 Jun 2026 02:06:00 GMTpharmaphorumhttp://www.bing.com/th?id=ONUT.hTbXEmNUHdQ7JDwL98Myzg&pid=Newsw={0}&h={1}&c=14960540http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2ffinance.yahoo.com%2fhealthcare%2farticles%2fbiogen-adds-more-immune-drugs-111200714.html&c=1694251954610638105&mkt=en-usThe companies didn’t specify the drugs Biogen is acquiring in the deal, though patents RayThera secured provide important clues.Thu, 18 Jun 2026 09:32:00 GMTYahoo Financehttp://www.bing.com/th?id=ONUT.kf048JQdxlyl8bXvhkJBKA&pid=Newsw={0}&h={1}&c=141200675http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fother%2fbiogen-to-acquire-raythera-for-up-to-1-billion-expanding-immunology-pipeline%2far-AA25Ydc1&c=13425977815689289370&mkt=en-usBiogen Inc. BIIB on Wednesday agreed to acquire private biotechnology company RayThera Inc. for up to $1 billion. The company looks to further expand its immunology pipeline and broaden its reach into ...Thu, 18 Jun 2026 08:07:15 GMTBenzinga on MSNhttp://www.bing.com/th?id=ONUT.2sr4QdxAbswvF1gzQiYbxg&pid=Newsw={0}&h={1}&c=141000430http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fwww.fiercebiotech.com%2fbiotech%2fbiogen-inks-1b-raythera-buyout-bag-preclinical-immunology-assets&c=2851838858416414256&mkt=en-usBiogen has struck a backloaded, $1 billion deal to buy RayThera, snagging a pipeline of anti-inflammatory drug candidates led by a prospect on the cusp of clinical development.Thu, 18 Jun 2026 01:10:00 GMTFierce Biotechhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fmarkets.businessinsider.com%2fnews%2fstocks%2fbiogen-expands-immunology-pipeline-with-agreement-to-acquire-raythera-inc-1036258155&c=14226752205493610747&mkt=en-usBiogen Inc. (Nasdaq: BIIB) and RayThera Inc., a private biotechnology company focused on discovering and developing small molecule therapies in immunology, today announced the companies have entered ...Wed, 17 Jun 2026 16:18:00 GMTMarkets Insiderhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fwww.bizjournals.com%2fboston%2fnews%2f2026%2f06%2f18%2fbiogen-raythera-acquisition.html&c=4208556395310242836&mkt=en-usBiogen will acquire San Diego's RayThera for up to $1B, expanding its immunology pipeline with early-stage anti-inflammatory drug candidates.Thu, 18 Jun 2026 07:21:00 GMTThe Business Journalshttp://www.bing.com/th?id=ONUT.zphG8zgw1nVGcgpXaEAGZQ&pid=Newsw={0}&h={1}&c=141200675http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fwww.thepharmaletter.com%2fbiotech-news%2fbiogen-expands-immunology-pipeline-with-raythera-buy&c=20646918981343736&mkt=en-usContinuing the strong M&A activity in the pharma/biotech sector, US biotech major Biogen has announced a second acquisition this year.Thu, 18 Jun 2026 03:46:00 GMTThe Pharma Letterhttp://www.bing.com/th?id=ONUT.BvmwyzVP5db_mKzRrieP9A&pid=Newsw={0}&h={1}&c=14700466http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fwww.cnbc.com%2f2026%2f05%2f14%2fbiogen-alzheimers-drug-moves-to-late-stage-trial.html&c=2349078560773937017&mkt=en-usBiogen said signals suggest the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.Thu, 14 May 2026 08:23:00 GMTCNBChttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fwww.marketwatch.com%2fstory%2fbiogen-gets-fda-breakthrough-designation-for-spinraza-successor-salanersen-42d1c6c5&c=2733928922439145013&mkt=en-usBiogen has won U.S. Food and Drug Administration breakthrough-therapy designation for its proposed salanersen treatment for the neuromuscular disease spinal muscular atrophy, or SMA. The Cambridge, ...Thu, 04 Jun 2026 05:07:00 GMTMarketWatchhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34aa9e984f4d6db6478e2613867874&url=https%3a%2f%2fwww.contractpharma.com%2fbreaking-news%2fbiogen-agrees-to-acquire-raythera-for-up-to-1b%2f&c=7682745906251195508&mkt=en-usBiogen has agreed to acquire RayThera Inc., a private biotechnology company focused on discovering and developing small molecule therapies in immunology.Thu, 18 Jun 2026 06:15:00 GMTContract Pharmahttp://www.bing.com/th?id=ONUT.JrEgszgV6gD3wBb58qgi0w&pid=Newsw={0}&h={1}&c=14800800